- Home
- SIGIP vs FBIOP Comparison
SIGIP vs FBIOP Comparison
Compare SIGIP & FBIOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
SIGIP
Selective Insurance Group Inc. Depositary Shares each representing a 1/1000th interest in a share of 4.60% Non-Cumulative Preferred Stock Series B
Current Price
Company Overview
Basic Information| Metric | SIGIP | FBIOP |
|---|---|---|
| Founded | N/A | N/A |
| Country | United States | United States |
| Employees | 2800 | 78 |
| Industry | Property-Casualty Insurers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | N/A |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | SIGIP | FBIOP |
|---|---|---|
| Price | $15.73 | $18.80 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 40.4K | 12.3K |
| Earning Date | N/A | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $15.45 | $6.27 |
| 52 Week High | $18.71 | $21.43 |
Technical Indicators
Market Signals| Indicator | SIGIP | FBIOP |
|---|---|---|
| Relative Strength Index (RSI) | 42.21 | 44.71 |
| Support Level | $15.50 | $17.90 |
| Resistance Level | $16.17 | $19.00 |
| Average True Range (ATR) | 0.10 | 0.30 |
| MACD | -0.00 | -0.05 |
| Stochastic Oscillator | 0.00 | 45.80 |
Price Performance
Historical ComparisonAbout SIGIP Selective Insurance Group Inc. Depositary Shares each representing a 1/1000th interest in a share of 4.60% Non-Cumulative Preferred Stock Series B
Selective Insurance Group Inc is a regional property-casualty insurer based in New Jersey, with its operations focused in the New York metropolitan area. The Company has four operating segments: Standard Commercial Lines, Standard Personal Lines, E&S Lines, and Investments. Majority of revenue is gained from Standard Commercial Lines segment, which comprises of property and casualty insurance products and services provided in the standard marketplace to commercial enterprises, which are typically businesses, non-profit organizations, and local government agencies.
About FBIOP Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development.